Do β-blockers really enhance the risk of anaphylaxis during immunotherapy?

Current Allergy and Asthma Reports

Volumn 8, Issue 1, 2008, Pages 37-44

  Lang, David M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ALLERGEN; AMOXICILLIN; ANTITHROMBOCYTIC AGENT; ATENOLOL; BENDROFLUMETHIAZIDE PLUS NADOLOL; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; CALCIUM CHANNEL STIMULATING AGENT; CARTEOLOL; CARVEDILOL; CONTRAST MEDIUM; CYCLIC AMP; GLUCAGON; HYDROCHLOROTHIAZIDE PLUS PROPRANOLOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYMENOPTERA VENOM; LABETALOL; METOPROLOL; METOPROLOL TARTRATE; NADOLOL; PENBUTOLOL; PLACEBO; POLLEN EXTRACT; PROPRANOLOL; SOTALOL; TIMOLOL MALEATE; UNINDEXED DRUG; VENOM;

ALLERGIC ASTHMA; ALLERGIC DISEASE; ALLERGIC RHINITIS; ANAPHYLAXIS; ANGIOCARDIOGRAPHY; BRONCHODILATATION; BRONCHOSPASM; CARDIOSELECTIVITY; CASE STUDY; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG POTENTIATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EVIDENCE BASED PRACTICE; FEASIBILITY STUDY; HEART INFARCTION; HISTAMINE RELEASE; HUMAN; HYPERTENSION; HYPOTENSION; IMMUNOTHERAPY; INSECT ALLERGY; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PRESCRIPTION; RECEPTOR BLOCKING; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TREATMENT DURATION;

ADRENERGIC BETA-ANTAGONISTS; ANAPHYLAXIS; CASE-CONTROL STUDIES; COHORT STUDIES; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY;

EID: 41549127645     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-008-0008-8     Document Type: Review

References (52)

1. Webster's Encyclopedic Unabridged Dictionary of the English Language. New York: Gramercy Books; 1996,
2. Allergen immunotherapy: a practice parameter. Ann Allergy 2003, 90(suppl):SI-S540.
3. Walker S, Pajno GB, Lima MT, et al.: Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized controlled trial. J Allergy Clin Immunol 2001, 107:87-93.
4. Matloff SM, Bailit IW, Parks P, et al.: Systemic reactions to immunotherapy. Allergy Proc 1993, 14:347-350.
5. Hepner M, Ownby D, Anderson J, et al.: Risk of systemic reactions in patients taking beta blocker drugs receiving immunotherapy injections. J Allergy Clin Immunol 1990, 86:407-411.
6. Cazzola M: Application of number needed to treat (NNT) as a measure of treatment effect in respiratory medicine. Treat Respir Med 2006, 5:79-84.
7. Hunt KJ, Valentine MD, Sobotka AK, et al.: A controlled trial of immunotherapy in insect hypersensitivity. N Engl J Med 1978, 299:157-161.
8. Yusuf S, Peto R, Lewis J, et al.: Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985, 27:335-371.
9. Gottlieb SS, McCarter RJ, Vogel RA: Effect of beta blockade on mortality among high risk and low risk patients after myocardial infarction. N Engl J Med 1998, 339:489-497.
10. Ong HT: Beta blockers in hypertension and cardiovascular disease. BMJ 2007, 334:946-949.
11. Patterns of medication use in the United States 2005: a report from the Slone Survey. Available at http://www.bu.edu/slone/SloneSurvey/ AnnualRpt/SloneSurveyWebReport2005.pdf. Accessed September 2, 2007.
12. Frishman WH: Beta-adrenergic blockers. Med Clin North Am 1988, 72:37-81.
13. McNeill RS: Effect of a beta-adrenergic blocking agent, propranolol on asthmatics. Lancet 1964, 2:1101-1102.
14. Odeh M, Oliven A, Bassan H: Timolol eyedrop-induced fatal bronchospasm in an asthmatic patient. J Fam Prac 1991, 32:97-98.
15. Madowitz JS, Schweiger MJ: Severe anaphylactoid reaction to radiographic contrast media. JAMA 1979, 241:2813-2815.
16. Jacobs RL, Rake GW, Fournier DC, et al.: Potentiated anaphylaxis in patients with drug-induced beta-adrenergic blockade. J Allergy Clin Immunol 1981, 68:125-127.
17. Newman BR, Schultz LK: Epinephrine-resistant anaphylaxis in a patient taking propranolol hydrochloride. Ann Allergy 1981, 47:35-37.
18. Awai LW, Mekori YA: Insect sting anaphylaxis and beta-adrenergic blockade: a relative contraindication. Ann Allergy 1984, 53:48-49.
19. Laxenaire MC, Torrens J Moneret-Vautrin DA: Choc anaphylactoide mortel chez un malade traite par beta bloquants. Ann Fr Anesth Reanim 1984, 3:453-455.
20. Benitah E, Nataf P, Herman D: Accidents anaphylactiques chez des patients traites par beta-bloquants. Therapie 1986, 41:139-142.
21. Cornaille G, Leynadier F, Modiano, Dry J: Gravite du choc anaphylactique chez les malades traites par beta-bloquers. Presse Med 1985, 14:790-791.
22. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC: Fatalities from immunotherapy and skin testing. J Allergy Clin Immunol 1987,660-677.
23. Toogood JH: Beta-blocker therapy and the risk of anaphylaxis. Can Med Assoc J 1987, 136:929-932.
24. Berkelman RL, Finton RJ, Elsen WR: Beta-adrenergic antagonists and fatal anaphylactic reactions to oral penicillin. Ann Intern Med 1986, 104:134.
25. Capellier G, Boillot A, Cordier A, et al.: Choc anaphylactique chez les alades sous betabloquers. Presse Med 1989, 18:181.
26. Stark BJ, Sullivan TJ: Biphasic and protracted anaphylaxis. J Allergy Clin Immunol 1986, 78:76-83.
27. Hamilton G: Severe adverse reactions to urography in patients taking beta-adrenergic blocking agents. Can Med Assoc J 1985, 133:122-126.
28. Zaloga GP, Delacey W, Holmboe E, et al.: Glucagon reversal of hypotension in a case of anaphylactoid shock. Ann Intern Med 1986, 105:65-66.
29. Javeed N, Javeed H, Javeed S, et al.: Refractory anaphylactoid shock potentiated by beta blockers. Cathet Cardiovasc Diagn 1996, 39:383-384.
30. Kivity S, Yarchopysky J: Relapsing anaphylaxis to bee sting in a patient treated with beta blocker and Ca blocker. J Allergy Clin Immunol 1990, 85:669-670.
31. Goddet NS, Descatha A, Liberge O, et al.: Paradoxical reaction to epinephrine induced by beta blockers in an anaphylactic shock induced by penicillin. Eur J Emerg Med 2006, 13:358-360.
32. Corbascio AN: Propranolol [letter]. Clin Pbarmacol Thera 1971, 12:5S9-560.
33. Shereff RH, Harwell W, Lieberman P, et al.: Effect of beta-adrenergicstimulation and blockade on immediate hypersensitivity skin test reactions. J Allergy Clin Immunol 1973, 52:328-333.
34. Sventivanyi A: The beta adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy 1968, 42:203-232.
35. Kaliner M, Shelhamer JH, Davis PB, et al.: Autonomic nervous system abnormalities and allergy. Ann Intern Med 1982, 96:349-357.
36. Nisam MR, Zbinden A Chesrown S, et al.: Distribution and pharmacological release of histamine in canine lung in vivo. J Appl Physiol 1978, 44:455-463.
37. Matsumura Y, Tan EM, Vaughn JH: Hypersensitivity to histamine and systemic anaphylaxis in mice with pharmacologic beta adrenergic blockade: protection by nucleotides. J Allergy Clin Immunol 1976, 58:387-394.
38. Motulsky HJ, Inset PA: Adrenergic receptors in man. Direct identification, physiologic regulations, and clinical alterations. N Engl J Med 1982, 307:18-29.
39. Toogood JH: Risk of anaphylaxis in patients receiving betablocker drugs. J Allergy Clin Immunol 1988, 81:1-3.
40. Lieberman P, Kemp S, Oppenheimer J, et al.: The Diagnosis and Management of Anaphylaxis: An Updated Practice Parameter. J Allergy Clin Immunol 2005, 115:S483-523.
41. Kaliner M, Dyer J, Merlin S, et at.: Increased histamine in contrast media reactions. Invest Radiol 1984, 19:116-118.
42. Rosenfield AT, Littner MR, Ulreich S, et at.: Respiratory effects of excretory urography: a preliminary report. Invest Radiol 1977, 12:295-298.
43. Neagley SR, Vought MB, Weidner WA, Zwillich CW: Transient oxygen desaturation following radiographic contrast medium administration. Arch Intern Med 1986, 146:1094-1097.
44. American Academy of Allergy and Immunology: Beta-Adrenergic blockers, immunotherapy, and skin testing [position statement]. J Allergy Clin Immunol 1989, 84:129-130.
45. Guyatt G, Rennie D, eds: Users' Guide to the Medical Literature. Atlanta: AMA Press; 2002.
46. Greenberger PA, Meyers SN, Kramer BL: Effects of beta adrenergic and calcium antagonists on the development of anaphylactoid reactions from radiographic contrast media during cardiac angiography. J Allergy Clin Immunol 1987, 80:698-702.
47. Müller UR, Haeberli G: Use of beta blockers during immunotherapy for Hymenoptera venom allergy. J Allergy Clin Immunol 2005, 115:606-610.
48. Lang DM, Alpern MB, Visintainer PF, Smith ST: Increased risk for anaphylactoid reaction from contrast media in patients on beta-adrenergic blockers or with asthma. Ann Intern Med 1991, 115:270-276.
49. Lang DM, Alpern MB, Visintainer PF, Smith ST: Elevated risk of anaphylactoid reaction from radiographic contrast media is associated with both beta-blocker exposure or cardiovascular disorders. Arch Intern Med 1993, 153:2033-2040.
50. Barret-Bee K, Lees J: The nature of the beta-adrenoceptor involved in the inhibition of antigen-induced histamine release. Biochem Biopbys Res Commun 1978, 84:998-1002.
51. Butchers PR, Skidmore IF, Vardey CJ, Wheeldon A: Characterization of the receptor mediating the anti-anaphylactic effects of beta-adrenoceptor agonists in human lung tissue in vitro. Br J Pharmac 1980, 71:663-667.
52. Sherman MS, Lazar EJ, Eichacker P: A bronchodilator action of glucagon. J Allergy Clin Immunol 1988, 81:908-911.